Bruce A. Sebek
About
In The Last Decade
Bruce A. Sebek
42 papers receiving 950 citations
Peers
Comparison fields: 5 of 85
- Surgery 393
- Oncology 288
- Pulmonary and Respiratory Medicine 245
- Pathology and Forensic Medicine 195
- Rheumatology 151
Countries citing papers authored by Bruce A. Sebek
This map shows the geographic impact of Bruce A. Sebek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce A. Sebek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce A. Sebek more than expected).
Fields of papers citing papers by Bruce A. Sebek
This network shows the impact of papers produced by Bruce A. Sebek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce A. Sebek. The network helps show where Bruce A. Sebek may publish in the future.
Co-authorship network of co-authors of Bruce A. Sebek
This figure shows the co-authorship network connecting the top 25 collaborators of Bruce A. Sebek. A scholar is included among the top collaborators of Bruce A. Sebek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce A. Sebek. Bruce A. Sebek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 7 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 57 | |
| 6 | 29 | |
| 7 | 89 | |
| 8 | 3 | |
| 9 | 33 | |
| 10 | 23 | |
| 11 | 19 | |
| 12 | 18 | |
| 13 | 7 | |
| 14 | 16 | |
| 15 | Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation. | 78 |
| 16 | 59 | |
| 17 | 24 | |
| 18 | 23 | |
| 19 | 36 | |
| 20 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.